The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury
1 other identifier
observational
66
1 country
1
Brief Summary
The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term. 20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 10, 2023
CompletedFirst Posted
Study publicly available on registry
August 18, 2023
CompletedAugust 18, 2023
August 1, 2023
1 year
August 10, 2023
August 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Adiponectin level
Adiponectin level will be measured from peripheral blood
Will be measured at inclusion
DASH diet score
Will be measured at inclusion from one day dietary record
Will be measured at inclusion from one day dietary record
Mediterrenian diet score
Will be measured at inclusion from one day dietary record
Will be measured at inclusion from one day dietary record
Secondary Outcomes (6)
Whole blood count
Will be measured at inclusion
Fasting blood glucose
Will be measured at inclusion
Total cholesterol
Will be measured at inclusion
LDL
Will be measured at inclusion
HDL
Will be measured at inclusion
- +1 more secondary outcomes
Study Arms (2)
Patients with spinal cord injury
Healthy group
Interventions
Checking and receiving the 1-day food consumption record recorded by the patient by the researcher
Adiponectin level will be measured for each group
Eligibility Criteria
Patients admitted to hospital Healthy population from patient care givers of hospital staff
You may qualify if:
- Having spent at least 6 months after spinal cord injury
- st motor neuron injury
- Being between the ages of 18-65
- Being between the ages of 18-65
- Giving consent to participate in the study
You may not qualify if:
- Having an additional disease to the spinal cord injury
- Having a 2nd motor neuron lesion
- Having any disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital Physical Treatment and Rehabilitation Hospital
Ankara, Turkey (Türkiye)
Related Publications (3)
Wang YH, Huang TS, Liang HW, Su TC, Chen SY, Wang TD. Fasting serum levels of adiponectin, ghrelin, and leptin in men with spinal cord injury. Arch Phys Med Rehabil. 2005 Oct;86(10):1964-8. doi: 10.1016/j.apmr.2005.04.017.
PMID: 16213239BACKGROUNDEkmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost. 2006 Apr;12(2):163-8. doi: 10.1177/107602960601200203.
PMID: 16708117BACKGROUNDO'Brien LC, Graham ZA, Chen Q, Lesnefsky EJ, Cardozo C, Gorgey AS. Plasma adiponectin levels are correlated with body composition, metabolic profiles, and mitochondrial markers in individuals with chronic spinal cord injury. Spinal Cord. 2018 Sep;56(9):863-872. doi: 10.1038/s41393-018-0089-8. Epub 2018 Mar 20.
PMID: 29559683BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 10, 2023
First Posted
August 18, 2023
Study Start
March 1, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
August 18, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share